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Background: Abnormal endothelial function promotes atherosclerotic vascular disease in diabetes. Experimental studies indicate that disruption 
of endothelial insulin signaling through activation of protein kinase C-` (PKC`) and nuclear factor gB (NFgB) reduces nitric oxide activity. We 
sought to establish whether similar mechanisms operate in the endothelium in human diabetes.
Methods and Results: We measured protein expression and insulin response in freshly isolated endothelial cells obtained by j-wire biopsy from 
human subjects with diabetes (n=28) and non-diabetic controls (n=24). We observed unexpectedly higher basal endothelial nitric oxide synthase 
(eNOS) phosphorylation in diabetes (52±5 versus 29±2, P=0.002) without a difference in total eNOS expression. Insulin stimulation increased eNOS 
phosphorylation in nondiabetic subjects but not in diabetic patients (+39±12 vs -13±3, P=0.0001) consistent with the presence of endothelial 
insulin resistance in diabetes. Inhibition of PKC` with LY379196 normalized basal eNOS phosphorylation and restored insulin-mediated eNOS 
activation in endothelial cells from patients with diabetes. Measures of endothelial NFgB activation including higher p65, lower IgB_, and higher 
intracellular adhesion molecule (ICAM) expression were present in diabetes. Patients with diabetes had endothelial dysfunction with lower flow-
mediated dilation compared with controls (5.9±4.4% vs. 9.8±3.5%, P=0.001).
Conclusions: We provide direct evidence for the presence of altered eNOS activation, reduced insulin action and inflammatory activation in the 
endothelium of patients with diabetes. Our findings implicate increased PKC` activity in vascular insulin resistance.
